Lumicell initiates pivotal trial for breast cancer surgical guidance solution

Lumicell is a previous MLSC awardee through the Center’s Accelerator Loan Program

Kudos to Newton-based Lumicell, which recently announced it had begun a pivotal trial of the company’s imaging system for breast cancer, a major milestone on the path toward FDA submission for approval.

Lumicell is a previous MLSC awardee through our Accelerator Program, which provided loans of up to $1 million to early-stage companies engaged in life sciences research and development, commercialization, and manufacturing.

Share This Post

MLSC Brandmark scaled 1